Why the study?
Retroperitoneal liposarcomas present surgical challenges due to their large size, adjacent organ involvement, and high recurrence risk, with roles for chemotherapy or radiotherapy undefined.
Case report highlighting the surgical management of a giant retroperitoneal liposarcoma.
Large retroperitoneal liposarcomas may cause bowel obstruction; this case leaves optimal management strategies open for further study.
Retroperitoneal tumors are rare neoplasms that can reach great dimensions due to a slow growth pattern. Although these tumors rarely metastasize, they have a great risk of recurrence, and majority of times these lesions are a challenge for the surgeon. We report the case of a 63-year-old woman who presented with symptoms of large bowel obstruction and was diagnosed with a large heterogenous mass located in the retroperitoneal space. The fine needle biopsy revealed the histology of liposarcoma. The purpose of this article is to report our approach in management of this kind of tumor. Tumor size (27.1 × 29.1 × 36.1 cm) and involvement to the adjacent organs was a challenge for us in order to reach safe oncological margins. In these cases, the risk of recurrence is high; therefore, the patient should be screened at 6, 12 and 24 months post procedure. Chemotherapy or radiotherapy for this tumor is not yet defined, and if operable, surgery is the treatment of choice.
No takes yet. Share an insight, caveat, or question.
Gutu et al. (2023) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: